As mentioned above, the HER2-enriched tumours are one of the subtypes defined by the PAM50 BC tumour subtyping and are characterised with the highest ERBB2 gene expression amongst all subtypes both at RNA and protein level. The gene discussed is ERBB2; the disease is breast cancer.